Moran Grossman

Title: Moran Grossman: Innovator in Antibody Generation

Introduction

Moran Grossman is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the generation of antibodies for therapeutic applications. With a total of 2 patents, his work focuses on innovative methods that have the potential to impact medical treatments.

Latest Patents

Grossman's latest patents include groundbreaking methods for generating antibodies to metalloenzymes. This method involves immunizing a subject to produce antibodies that inhibit metalloenzymes, which are crucial in various biological processes. Another significant patent involves antibodies targeted against LOXL-2, aimed at treating collagen-associated pathologies. This invention comprises a combination of active agents, including an anti-cancer or antifibrotic agent, which works to downregulate the activity of lysyl-oxidase like protein-2 (LOXL-2) and alter the structure of the extracellular matrix.

Career Highlights

Moran Grossman is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of various diseases.

Collaborations

Some of his notable coworkers include Irit Sagi and Nir Ben-Chetrit, who collaborate with him on various research projects. Their combined expertise enhances the potential impact of their innovations in the field.

Conclusion

Moran Grossman stands out as an influential inventor in the biotechnology sector, with a focus on antibody generation that holds promise for future medical advancements. His contributions are paving the way for new therapeutic strategies in treating complex diseases.